PT3341725T - Métodos para detetar alfa-sinucleína fosforilada - Google Patents
Métodos para detetar alfa-sinucleína fosforiladaInfo
- Publication number
- PT3341725T PT3341725T PT167660885T PT16766088T PT3341725T PT 3341725 T PT3341725 T PT 3341725T PT 167660885 T PT167660885 T PT 167660885T PT 16766088 T PT16766088 T PT 16766088T PT 3341725 T PT3341725 T PT 3341725T
- Authority
- PT
- Portugal
- Prior art keywords
- sinuclein
- phosphoryl
- alpha
- detect
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562209800P | 2015-08-25 | 2015-08-25 | |
| US201662297777P | 2016-02-19 | 2016-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3341725T true PT3341725T (pt) | 2021-09-21 |
Family
ID=56926235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167660885T PT3341725T (pt) | 2015-08-25 | 2016-08-25 | Métodos para detetar alfa-sinucleína fosforilada |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10852309B2 (enExample) |
| EP (1) | EP3341725B1 (enExample) |
| JP (2) | JP6989927B2 (enExample) |
| CA (1) | CA2994518C (enExample) |
| DK (1) | DK3341725T3 (enExample) |
| ES (1) | ES2890073T3 (enExample) |
| HU (1) | HUE056054T2 (enExample) |
| PT (1) | PT3341725T (enExample) |
| WO (1) | WO2017033152A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6989927B2 (ja) | 2015-08-25 | 2022-02-03 | プロセナ バイオサイエンシーズ リミテッド | リン酸化アルファ－シヌクレインを検出するための方法 |
| RU2019114679A (ru) | 2016-11-15 | 2020-12-17 | Х. Лундбекк А/С | Средства, пути применения и способы лечения синуклеопатии |
| EP3548074A4 (en) | 2016-12-02 | 2020-07-01 | Prothena Biosciences Limited | INFRARED ASSAY DETECTING SECONDARY ALPHA-SYNUCLEIN STRUCTURE PROFILES |
| EP3555127B1 (en) | 2016-12-16 | 2024-12-18 | H. Lundbeck A/S | Agents, uses and methods |
| JP7136790B2 (ja) | 2017-02-17 | 2022-09-13 | ブリストル－マイヤーズ スクイブ カンパニー | アルファ－シヌクレインに対する抗体およびその使用 |
| GB201720970D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Antibodies |
| GB201720975D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Anti-alpha synuclein antibodies |
| JP7498663B2 (ja) * | 2017-12-21 | 2024-06-12 | ハー・ルンドベック・アクチエゼルスカベット | アルファ－シヌクレイン病のアッセイ、方法、及び治療 |
| GB201803553D0 (en) | 2018-03-06 | 2018-04-18 | Univ Newcastle | Detection of pathological protein aggregation |
| WO2020146497A1 (en) * | 2019-01-09 | 2020-07-16 | The Regents Of The University Of California | An electrochemiluminescence elisa for ps129-a-synuclein |
| MX2022006676A (es) * | 2019-12-04 | 2022-07-05 | Ac Immune Sa | Nuevas moleculas para terapia y diagnostico. |
| CN112710850A (zh) * | 2020-12-29 | 2021-04-27 | 苏州百志生物科技有限公司 | 一种检测人体液中α-突触核蛋白含量的试剂盒 |
| WO2024163454A1 (en) * | 2023-01-30 | 2024-08-08 | The Regents Of The University Of California | A duplex electrochemiluminescence immunoassay for total α-synuclein and ps129-α-synuclein |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| EP0279582A3 (en) | 1987-02-17 | 1989-10-18 | Pharming B.V. | Dna sequences to target proteins to the mammary gland for efficient secretion |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| ES2109945T3 (es) | 1990-06-01 | 1998-02-01 | Chiron Corp | Composiciones y procedimientos para identificar moleculas biologicamente activas. |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| WO1994010569A1 (en) * | 1992-10-26 | 1994-05-11 | Schenk Dale B | METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| US5914241A (en) | 1993-01-19 | 1999-06-22 | Biosite Diagnostics, Inc. | Assays and kits for detecting analytes in the presence of cross-reacting substances |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5965375A (en) | 1997-04-04 | 1999-10-12 | Biosite Diagnostics | Diagnostic tests and kits for Clostridium difficile |
| US20080014194A1 (en) * | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
| US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| WO2005047860A2 (en) | 2003-11-08 | 2005-05-26 | Elan Pharmaceuticals, Inc. | Antibodies to alpha-synuclein |
| US7572640B2 (en) | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
| EP2527369A3 (en) * | 2007-09-13 | 2012-12-19 | University Of Zurich Prorektorat Forschung | Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| CN103782171B (zh) | 2011-07-13 | 2016-12-14 | 默沙东公司 | 用于检测流体样品中淀粉状蛋白β寡聚体的方法及其用途 |
| JP6989927B2 (ja) | 2015-08-25 | 2022-02-03 | プロセナ バイオサイエンシーズ リミテッド | リン酸化アルファ－シヌクレインを検出するための方法 |
-
2016
- 2016-08-25 JP JP2018510519A patent/JP6989927B2/ja active Active
- 2016-08-25 US US15/247,598 patent/US10852309B2/en active Active
- 2016-08-25 ES ES16766088T patent/ES2890073T3/es active Active
- 2016-08-25 HU HUE16766088A patent/HUE056054T2/hu unknown
- 2016-08-25 DK DK16766088.5T patent/DK3341725T3/da active
- 2016-08-25 PT PT167660885T patent/PT3341725T/pt unknown
- 2016-08-25 WO PCT/IB2016/055088 patent/WO2017033152A1/en not_active Ceased
- 2016-08-25 EP EP16766088.5A patent/EP3341725B1/en active Active
- 2016-08-25 CA CA2994518A patent/CA2994518C/en active Active
-
2020
- 2020-10-30 US US17/086,158 patent/US20210165000A1/en not_active Abandoned
-
2021
- 2021-07-28 JP JP2021122883A patent/JP7244949B2/ja active Active
-
2023
- 2023-01-26 US US18/160,270 patent/US20230228772A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7244949B2 (ja) | 2023-03-23 |
| CA2994518C (en) | 2025-05-06 |
| US20210165000A1 (en) | 2021-06-03 |
| JP6989927B2 (ja) | 2022-02-03 |
| HUE056054T2 (hu) | 2022-02-28 |
| US20170192017A1 (en) | 2017-07-06 |
| US10852309B2 (en) | 2020-12-01 |
| EP3341725B1 (en) | 2021-08-18 |
| JP2018526642A (ja) | 2018-09-13 |
| ES2890073T3 (es) | 2022-01-17 |
| CA2994518A1 (en) | 2017-03-02 |
| US20230228772A1 (en) | 2023-07-20 |
| EP3341725A1 (en) | 2018-07-04 |
| JP2021193374A (ja) | 2021-12-23 |
| DK3341725T3 (da) | 2021-09-06 |
| WO2017033152A1 (en) | 2017-03-02 |
| HK1257103A1 (en) | 2019-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249981A0 (en) | Method | |
| DK3139999T3 (da) | Forbedret neutral måling | |
| DE112015005628A5 (de) | Steckverbinder | |
| LT3149345T (lt) | Būdas dviem objektams sujungti | |
| PL3274725T3 (pl) | Sposoby wykrywania apolipoprotein | |
| EP2998732C0 (en) | ANALYSIS PROCESS | |
| IL252086A0 (en) | Novel methods | |
| DE202014104222U8 (de) | Steckverbinder | |
| HUE047581T2 (hu) | Készítmény | |
| EP3171776C0 (de) | Abbildungsanordnung | |
| FI20165066A (fi) | Lattiakaivon insertti | |
| DK3371522T3 (da) | Transpireret solfanger | |
| TH1601002523B (th) | วิธีการสร้างวัตถุ | |
| TH1601003915A (th) | ตัวเชื่อมต่อ | |
| UA29911S (uk) | Сухар | |
| TH1501007950B (th) | การเตรียมเป้าหมาย | |
| TH1501006654A (th) | วิธีการเชื่อมติดชิ้นส่วน | |
| ES1098331Y (es) | Abaco mejorado | |
| BR302014001854S1 (pt) | Configuração aplicada em bolsa | |
| BR302014001855S1 (pt) | Configuração aplicada em bolsa | |
| BR302014001504S1 (pt) | Configuração aplicada em prateleiras | |
| BR302014001055S1 (pt) | Configuração aplicada em bolsa | |
| BR302014000937S1 (pt) | Configuração aplicada em sandália | |
| BR302014002416S1 (pt) | Configuração aplicada em calçado | |
| BR302014002417S1 (pt) | Configuração aplicada em calçado |